The new standard of HCV therapy: Treatment in therapy-naive patients

Files
CLD-1-12.pdf (980.59 KB)
If you need an accessible version of this item, please email your request to digschol@iu.edu so that they may create one and provide it to you.
Date
2012-03-06
Authors
Agrawal, Saurabh
Kwo, Paul Y.
Language
American English
Embargo Lift Date
Department
Medicine, School of Medicine
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Wiley
Abstract
Description
Keywords
Hepatitis C virus (HCV), Pegylated interferon, Ribavirin, Nonstructural 3 protease inhibitors, Telaprevir (TVR), Boceprevir (BOC)
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Agrawal, S., & Kwo, P. Y. (2012). The new standard of HCV therapy: Treatment in therapy-naive patients. Clinical liver disease, 1(1), 12–15. doi:10.1002/cld.7
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Clinical Liver Disease
Rights
Publisher Policy
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/20554
DOI
https://doi.org/10.1002/cld.7
Version
Full Text Available at
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490699/
This item is under embargo {{howLong}}
Collections
Open Access Policy Articles
Department of Medicine Works